Susquehanna Growth Equity

Canaccord Genuity Advises Susquehanna Growth Equity on its Majority Investment in MediSpend

Canaccord Genuity is pleased to announce that it has advised Susquehanna Growth Equity (SGE), an entrepreneur-centric growth equity firm exclusively focused on software and information services companies, on its majority investment in MediSpend, a global technology company providing best-in-class solutions for the life sciences industry.  MediSpend was previously a portfolio company of EDG Partners. 

MediSpend enables some of the world's largest pharmaceutical, medical device, and emerging biotech companies to manage high-risk business functions compliantly through top-rated software and client services. The MediSpend Global Compliance Suite represents the industry's first global SaaS solution purpose-built to manage the end-to-end process of healthcare provider (HCP) engagement and includes transparency, engagement, and grants management functions all bundled together in a single software and workflow solution, enabling clients to manage increasingly complex reporting requirements seamlessly in different geographies across the globe.  MediSpend is headquartered in Portsmouth, New Hampshire, with offices in Minnesota, New York, Pennsylvania, and the Netherlands.

The new partnership with SGE will accelerate and support MediSpend's product and client expansion across the broader life sciences industry.  SGE's prior investments across the broader healthcare vertical include Evive, HMP Global, iContracts, MMIT, ProviderTrust, and RLDatix.  The firm has invested more than $2 billion in 60+ market-leading technology companies over the last 15 years and has portfolio companies across the US, Canada, EU, and Israel. SGE is backed by a unique and patient source of capital, enabling the firm to give entrepreneurs and management teams freedom and flexibility to maximize growth. 

Canaccord Genuity, with a team led by Tom O’Connor, served as exclusive financial advisor to Susquehanna Growth Equity.